AAAAAA

   
Results: 1-20 |
Results: 20
PENILE VIBRATORY STIMULATION AND ELECTROEJACULATION BEFORE ANTICANCERTHERAPY IN 2 PUBERTAL BOYS
Authors: SCHMIEGELOW ML SOMMER P CARLSEN E SONKSEN JOR SCHMIEGELOW K MULLER JR
Citation: Ml. Schmiegelow et al., PENILE VIBRATORY STIMULATION AND ELECTROEJACULATION BEFORE ANTICANCERTHERAPY IN 2 PUBERTAL BOYS, Journal of pediatric hematology/oncology, 20(5), 1998, pp. 429-430
MAINTENANCE CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - CLINICAL AND PHARMACOLOGICAL ASPECTS OF THE MONITORING AND ADJUSTMENT OF ORAL METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE
Authors: SCHMIEGELOW K
Citation: K. Schmiegelow, MAINTENANCE CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - CLINICAL AND PHARMACOLOGICAL ASPECTS OF THE MONITORING AND ADJUSTMENT OF ORAL METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE, Danish medical bulletin, 45(5), 1998, pp. 510-532
RELATION BETWEEN AGE, IMMUNOPHENOTYPE AND IN-VITRO DRUG-RESISTANCE IN395 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT OF INFANTS
Authors: PIETERS R DENBOER ML DURIAN M JANKA G SCHMIEGELOW K KASPERS GJL VANWERING ER VEERMAN AJP
Citation: R. Pieters et al., RELATION BETWEEN AGE, IMMUNOPHENOTYPE AND IN-VITRO DRUG-RESISTANCE IN395 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT OF INFANTS, Leukemia, 12(9), 1998, pp. 1344-1348
PHARMACOKINETICS, DOSE ADJUSTMENTS, AND 6-MERCAPTOPURINE METHOTREXATEDRUG-INTERACTIONS IN 2 PATIENTS WITH THIOPURINE METHYLTRANSFERASE DEFICIENCY/
Authors: ANDERSEN JB SZUMLANSKI C WEINSHILBOUM RM SCHMIEGELOW K
Citation: Jb. Andersen et al., PHARMACOKINETICS, DOSE ADJUSTMENTS, AND 6-MERCAPTOPURINE METHOTREXATEDRUG-INTERACTIONS IN 2 PATIENTS WITH THIOPURINE METHYLTRANSFERASE DEFICIENCY/, Acta paediatrica, 87(1), 1998, pp. 108-111
MATCHED UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENT MALIGNANT-LYMPHOMA IN A PATIENT WITH X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP)
Authors: HOFFMANN T HEILMANN C MADSEN HO VINDELOV L SCHMIEGELOW K
Citation: T. Hoffmann et al., MATCHED UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENT MALIGNANT-LYMPHOMA IN A PATIENT WITH X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP), Bone marrow transplantation, 22(6), 1998, pp. 603-604
IN-VITRO RESISTANCE TO PREDNISOLONE IS RELATED TO MINIMAL RESIDUAL DISEASE AT DAY-29 OF INDUCTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: KASPERS GJL NYVOLD C PIETERS R ROTTIER MMA KNABE N MADSEN HO RYDER LP SCHMIEGELOW K
Citation: Gjl. Kaspers et al., IN-VITRO RESISTANCE TO PREDNISOLONE IS RELATED TO MINIMAL RESIDUAL DISEASE AT DAY-29 OF INDUCTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 231-231
TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/
Authors: RAMAKERSVANWOERDEN NL PIETERS R KAZEMIER KM VANDRUNEN E HARBOTT J SEYFERT J BEVERLOO HB SLATER R VANWERING ER LUDWIG WD JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 231-231
IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT
Authors: RAMAKERSVANWOERDEN NL PIETERS R BEVERLOO HB LOONEN AH SLATER R VANWERING ER LUDWIG WD HARBOTT J JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 232-232
IMPACT OF MORNING VERSUS EVENING SCHEDULE FOR ORAL METHOTREXATE AND 6-MERCAPTOPURINE ON RELAPSE RISK FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHMIEGELOW K GLOMSTEIN A KRISTINSSON J SALMI T SCHRODER H BJORK O
Citation: K. Schmiegelow et al., IMPACT OF MORNING VERSUS EVENING SCHEDULE FOR ORAL METHOTREXATE AND 6-MERCAPTOPURINE ON RELAPSE RISK FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of pediatric hematology/oncology, 19(2), 1997, pp. 102-109
HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - GENE SEQUENCE POLYMORPHISMS
Authors: OTTERNESS D SZUMLANSKI C LENNARD L KLEMETSDAL B AARBAKKE J PARKHAH JO IVEN H SCHMIEGELOW K BRANUM E OBRIEN J WEINSHILBOUM R
Citation: D. Otterness et al., HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - GENE SEQUENCE POLYMORPHISMS, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 60-73
INHIBITION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PREVENTS DISSEMINATION AND INDUCES REMISSION OF JUVENILE MYELOMONOCYTIC LEUKEMIA IN ENGRAFTED IMMUNODEFICIENT MICE
Authors: IVERSEN PO LEWIS ID TURCZYNOWICZ S HASLE H NIEMEYER C SCHMIEGELOW K BASTIRAS S BIONDI A HUGHES TP LOPEZ AF
Citation: Po. Iversen et al., INHIBITION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PREVENTS DISSEMINATION AND INDUCES REMISSION OF JUVENILE MYELOMONOCYTIC LEUKEMIA IN ENGRAFTED IMMUNODEFICIENT MICE, Blood, 90(12), 1997, pp. 4910-4917
MYELOTOXICITY, PHARMACOKINETICS, AND RELAPSE RATE WITH METHOTREXATE 6-MERCAPTOPURINE MAINTENANCE THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/
Authors: SCHMIEGELOW K IFVERSEN M
Citation: K. Schmiegelow et M. Ifversen, MYELOTOXICITY, PHARMACOKINETICS, AND RELAPSE RATE WITH METHOTREXATE 6-MERCAPTOPURINE MAINTENANCE THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/, Pediatric hematology and oncology, 13(5), 1996, pp. 433-441
VARICELLA-ZOSTER INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: POULSEN A SCHMIEGELOW K YSSING M
Citation: A. Poulsen et al., VARICELLA-ZOSTER INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Pediatric hematology and oncology, 13(3), 1996, pp. 231-238
CURE OF X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP) WITH ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - REPORT FROM THE XLP REGISTRY
Authors: GROSS TG FILIPOVICH AH CONLEY ME PRACHER E SCHMIEGELOW K VERDIRAME JD VOWELS M WILLIAMS LL SEEMAYER TA
Citation: Tg. Gross et al., CURE OF X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP) WITH ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - REPORT FROM THE XLP REGISTRY, Bone marrow transplantation, 17(5), 1996, pp. 741-744
CHILDHOOD NON-HODGKINS-LYMPHOMA IN THE 5 NORDIC COUNTRIES - A 5-YEAR POPULATION-BASED STUDY FROM THE NORDIC SOCIETY OF PEDIATRIC HEMATOLOGYAND ONCOLOGY
Authors: MARKY I SCHMIEGELOW K PERKKIO M JONSSON OG STORMMATHIESEN I GUSTAFSSON G KREUGER A LANGMARK F
Citation: I. Marky et al., CHILDHOOD NON-HODGKINS-LYMPHOMA IN THE 5 NORDIC COUNTRIES - A 5-YEAR POPULATION-BASED STUDY FROM THE NORDIC SOCIETY OF PEDIATRIC HEMATOLOGYAND ONCOLOGY, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 163-166
TRANSIENT PANCYTOPENIA PRECEDING ACUTE LYMPHOBLASTIC-LEUKEMIA (PRE-ALL)
Authors: HASLE H HEIM S SCHROEDER H SCHMIEGELOW K OSTERGAARD E KERNDRUP G
Citation: H. Hasle et al., TRANSIENT PANCYTOPENIA PRECEDING ACUTE LYMPHOBLASTIC-LEUKEMIA (PRE-ALL), Leukemia, 9(4), 1995, pp. 605-608
RISK OF RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IS RELATED TO RBC METHOTREXATE AND MERCAPTOPURINE METABOLITES DURING MAINTENANCE CHEMOTHERAPY
Authors: SCHMIEGELOW K SCHRODER H GUSTAFSSON G KRISTINSSON J GLOMSTEIN A SALMI T WRANNE L
Citation: K. Schmiegelow et al., RISK OF RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IS RELATED TO RBC METHOTREXATE AND MERCAPTOPURINE METABOLITES DURING MAINTENANCE CHEMOTHERAPY, Journal of clinical oncology, 13(2), 1995, pp. 345-351
MONOCLONAL-ANTIBODIES TO THIOGUANINE - INFLUENCE OF COUPLING POSITIONON FINE SPECIFICITY
Authors: NERSTROM VM HENRIKSEN U NIELSEN PE BUCHARDT O SCHMIEGELOW K KOCH C
Citation: Vm. Nerstrom et al., MONOCLONAL-ANTIBODIES TO THIOGUANINE - INFLUENCE OF COUPLING POSITIONON FINE SPECIFICITY, Bioconjugate chemistry, 5(4), 1994, pp. 357-363
METHOTREXATE AND 6-MERCAPTOPURINE MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - DOSE ADJUSTMENTS BY WHITE CELL COUNTS ORBY PHARMACOKINETIC PARAMETERS
Authors: SCHMIEGELOW K SCHRODER H SCHMIEGELOW M
Citation: K. Schmiegelow et al., METHOTREXATE AND 6-MERCAPTOPURINE MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - DOSE ADJUSTMENTS BY WHITE CELL COUNTS ORBY PHARMACOKINETIC PARAMETERS, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 209-215
INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER
Authors: NIELSEN FC ORSKOV C HASELBACHER G RAMLAU J CHRISTIANSEN J SCHMIEGELOW K REHFELD JF
Citation: Fc. Nielsen et al., INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER, Cancer, 73(4), 1994, pp. 1312-1319
Risultati: 1-20 |